QUANTUM GENOMICS: Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity

Quantum Genomics Publishes its 2022 First Half Results
and Reviews its Activity
Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development

Related Keywords

United States ,France ,Taiwan ,Paris ,France General ,South Korea ,Turkey ,Brazil ,French ,American ,Jean Philippe Milon ,Catherine Llorens Cort ,Mike Tattory ,Gulf Pharmaceutical Industries Julphar ,American Heart Association ,Linkedin ,Twitter ,France French National Institute Of Health ,Drug Administration ,Scientific Centre For National Research ,Descartes University ,Quantum Genomics Publishes ,Euronext Growth ,Philippe Milon ,Quantum Genomics ,Middle East ,Independent States ,Statutory Auditor ,Brain Aminopeptidase ,Paris Descartes University ,French National Institute ,Medical Research ,Scientific Centre ,National Research ,Quantum ,Genomics ,Ublishes ,022 ,First ,Calf ,Results ,Reviews ,Activity ,